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HYPERPLASIA of the interstitial cells of the testis leading eventually to meta-
stasising carcinomas has been induced in certain strains of mice by means of
tri-phenyl-ethylene (Bonser and Robson, 1940 ; Gardner, 1943 ; Bonser, 1942 and
1944), oestradiol benzoate (Hooker, Gardner and Pfeiffer, 1940 I-looker and
Pfeiffer, 1942) and stflboestrol (Hooker, Gardner and Pfeiffer, 1940 ; Hooker and
Pfeiffer, 1942 ; Shimkin, Grady and Andervont, 1941).
It at first appeared (Hooker and Pfeiffer, 1942 ; Gardner 1943) that grafts of
these tumours would only grow in mice exposed to exogenous or endogenous
oestrogen, but Bonser (1944) successfuRy transplanted a tumour of this type to
normal males. Gardner (1945) found that transplants of an interstitial cell
tumour, induced by tri-phenyl-ethylene in a Strong A mouse, would not grow
in the absence of oestrogen, but persisted in a latent state. However, growth
followedtheimplantation ofstilboestrolpellets into thehost, even with an interval
,of 204 days between grafting and oestrogen treatment. Subsequent generations
ofthis tumour becameindependent and grew in both oestrogen andnon-oestrogen
treated mice (Gardner, personal communication).
According to Huseby (1954) transplants of an interstitial cell. tumour of the
testis grew in both male and female ca-strates. Treatment of intact male hosts
with LH or large doses of testosterone permitted transplants of this tumour to
grow, although LH inhibited its growth in castrated females. In the following
experiments the effects have been observed of various hormonal environments
onthelatentperiodofthegraftedinterstitial celltumourinducedbyBonser(I944).
MATERIALS.
The original tumour was transplanted in the FIL generation to a female, but
succeeding grafts grew in both normal males and females (Bonser, 1944). Up to
the 25th transplant generation no precise determination was made of the latent
period before active growth commenced. From the 25th generation onwards
the latent period was determined in each host and was found to be considerably
longerinfemalesthanin males(Table1). Withfurthertransplantationsthelatent
period decreased from 90 days in females ofthe 25th to 30 days in females ofthe
38thgeneration; similarlythe latentperiod in males diminished at about the same
rate in successivegenerations, but wa-salways less than in females.705 GRAFTED CARCINOMA OF TESTIS
TABLE I.-Latent Period of GrafM of a Te8ticular Tumour during the
25th-38th CTeneration of Tran8plant8.
Females. Males.
Transplant 14- 'N r- A
I
generation Number of Average latent Number of Average latent
No. mice. period (days). mice. period (days).
25 3 90 8 38
26 5 96 6 58
27 6 98 6 56
28 4 53 6 36
29 4 58 5 36
30 5 51 9 37
31 Not recorded Not recorded
32 0 5 35
33 4 62 4 30
34 5 33* 0
35 0 6 31
36 0 6 30
37 7 35 6 22
38 8 30 9 19
Ttiese mice were ovariectomised.
METHODS.
The tumour to be transplanted was removed aseptically and minced. Small,
approximately equal, amounts of this tissue were then transplanted by trocar
into the right groin of adult mice of the same strain. Each host was palpated
daily until the tumour graft could be felt as a small nodule about the size of the
inguinallymph node. The time after transplantation at which this occurred was
taken as the latent period. The tumour to be grafted was obtained from a male
host in all cases (except for Generation 35, when an ovariectomised female was the
donor).
The latent period of tumourgrafts was determined (Tables II andIII) in nor-
mal and castrated females and males (Experiments 1-4, 11-12), normal females
injected with testosterone (Experiment 5), castrated females or males treated with
oestradioldipropionate(Experiments 6, 7 and 13),triphenylethylene (Expe-ri'ments
8 and 14), =-(p-hydroxy-phenyl)-fl-bromo-ethylene (Experiment 16) or stilb-
oestrol (Experiments 10 and 17).
The quantities ofoestrogensinjected were all sufficient to maintain permanent
vaginal keratinisation in ovariectomised females, and the amount of testosterone
was sufficient to suppress all vaginal indications of oestrus.
The tumour tissues used comprised the 29th, 30th, 33rd and 38thgenerations
of grafts. The average latent period in normal females or normal males of
Generations 29, 30 and 33 did not vary greatly(Table1) and the results obtained
with tumours of these generations are thus considered to be directly comparable
and have been combined (Group A, Table II). However, the latent period
shorte-nedconsiderably between Generatio'ns 33 and 38, and so the results obtained
with Generation 38 of this tumour -cannot be directly compared with Group A,
and are consideredseparately (Group B, Table111).
The grafted tumour was removed surgically from 3 females ofExperiment I
afterithadattained adiameterofabout 2 cm. Aportion wasthenautotransplanted
to theoppositegroin and the latent period in this new site determined (Table IV).706 J. W. JULL
RESULTS.
.In Group A (Table 11) the average latent period in males (35 days) was not
affectedby castration (Experiments 2 and 4), but in females ovariectomy reduced
it from 56 to 36 days (Experiments I and 3). Treatment of castrated hosts with
oestradiol dipropionate (Experiments 6 and 7) or stilboestrol (Experiment I1)
increased the.average latent period from 36 to 120-121 days, but tri-phenyl-
TABLE 11. Group A : Effectof Variou8 Hormonal ConditiOn8 On the Latent Period
of aGrafted Testicular Tumour (Con8tituting the 29th, 30th and 33rd Generation8
ofTran8plant8).
Individual
latent
periods in
days.
70, 65, 65, 61,
57, 57, 57,
57, 55, 49,
46, 46, 41
Average
latent
period
(days).
56
Experi-
ment
NO.
1
Total
number of
mice.
. 13 .
Operative
Sex. treatment.
. F. . None.
Hormonal treatment.
None.
2 . M. . 18 55, 43, 39, 38,
36, 36, 35,
35, 35, 33,
32, 32, 32,
31, 30, 29,
29, 29
15 50, 46, 43, 43,
39, 38, 35,
33, 33, 33,
32, 29, 28,
28, 23
13 47, 43, 43, 38,
36, 35, 35,
34, 32, 32,
32, 29, 29
6 57, 57, 54, 52,
52P r,'")
8 197, 116, 113,
112, 108,
107, 107p
106
8 190, 185, 107,
105, 99, 99,
94, 83
5 42, 38, 36, 36,
36
35
3, - F. . Ovariectomy
.
4 - M. . Orchidectomy
.
36
36
5 . F. . None
6 . F. . Ovariectomy
7 . M. . Orchidectomy
8 . F. . Ovariectomy
. Injected 6 mg. testo-
sterone propionate
once per fortnight.
. Injected 50 yg. oestra-
diol dipropionate
once per fortnight.
. Injected 50 yg. oestra-
diol dipropionate
once per fornight.
. Injected 3 mg. triphe-
nylethylene once per
fortnight.
54
. 121
120
38
9 . F.
10 . F.
.9.9 . Injected 1-5 mg. tri-
phenylchlorethylene
once per fortnight
VSI . Injected 0-5 mg. stilb-
oestrol once per
fortnight.
5 . 35, 33, 31, 23,
23
1 . 120
29
. 120GRAFTED CARCINOMA OF TESTIS 70j'
ethylene (Experiment 8) and tri-phenyl-chlor-ethylene (Experiment 9) had no
effect.
In Group B (Table III), oestradioldipropionate (Experiment 13) and stilboes-
trol (Experiment 17) increased the latent period from 20 days to 30 days in
castrated hosts, whereas tri-phenyl-ethylene (Experiment 14), tri-phenyl-chlor-
ethylene (Experiment 15) and aa-(p-hydroxyphenyl)-,8-bromo-ethylene (Experi-
ment 16) had no effect. In this group, however, the average latent period
i
normal females was 30days and in normal males 20days, so that theprolongation
of the latent period by oestradiol dipropionate or stilboestrol was not so marked
as in Group A.
There were no significant variations in the latent period of auto-transplants
of the tumour in 3 females ofExperiment I (Table IV).
TABLE III.-Group B: Effect of Variow Hormonal Condition8 on the Latent
Period of a Grafted Te8ticular Tumour (Constituting the 38th Transplanted
Generation.)
Individual
latent
periods
(days).
31, 31, 31, 31,
31, 31, 24,
19
Average
latent
period
(days).
29
Experi-
ment
No.
11
Total
number
of mice.
. 8 .
Operative
Sex. treatment.
. F. . None.
Hormonal treatment.
None.
12 . M. . . 9 . 24, 20, 19, 19,
19, 19, 19,
19, 19
. 7 . 31, 31, 31, 31,
31, 31, 24
20
13 . F. . Ovariectomy
. Injected 50 mg. oestradiol
dipropionate once per
per fortnight.
Injected 3 mg. triphenyl-
ethylene once per fort-
night.
30
14 . F.
15 . F.
16 . F.
. 4 . 20, 20, 20, 19
. 6 . 20, 20, 20, 20,
20, 17
. 9 . 20, 20, 19, 19,
19, 19, 19,
18, 18
. 5 . 31, 31, 31, 27,
24
20
20
19
29
; 9
Injected 1-5 mg. tripho-
nylethylene once per
fortnight.
Injected 0-5 mg. aa-(p-
hydroxyphenyl) p
bromoethylene once
per fortnight.
Injected 0-5 mg. stilb-
oestrol once per fort-
night.
17 . F.
TABLE IV.-Latent Period8 of Te.3ticular Tumour, Grafted Fir8t into the Right
Groin and then Autotran,3planted to the Left Groin ofAdult Female Mice.
Latent period of
autotransplant
into left groin
(days).
57
57
42
Latent period of first
graft in right groin
(days).
61
59
63
Mouse No.
1
2
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Once growth had commenced it continued progressively in all grafts despite
continued oestrogen treatment. At no time during the observation of this
tumour was there variation of its microscopic appearance.
DISCUSSION.
These experiments were commenced 8 years after the induction and first
grafting of the interstitial cell tumour of the testis. The shortening of the latent
period which occurred during the next 2 years seems to have taken placestep-wise
and not as a gradual decrease (Table 1), and at the same time the susceptibility of
the latent period to certain oestrogens was also reduced (Tables TI and 111).
This increased independence of the hormonal environment with time conforms
to the concept ofprogression (Foulds, 1949) and is paralleled by the behaviour of
the interstitial cell tumour investigated by Gardner (1945) which eventually grew
freely in both oestrogen and non-oestrogen treated animals. It is reasonable to
suppose that the tumour used here was hormone-responsive when it arose, and
if that were so the period of 10 years during which it remained responsive was a
long one, being at least 4 times the normal life of a mouse.
The results of the experiments in Group B, although not directly comparable
with those of Group A, are confirmatory in that the latent period of grafts was
influenced by hormonal treatments in the same directionalthough not to the same
extent.
As the latent period ofgrafts was less in castrated than in normal females, but
was the same in both normal and castrated males, it follows that the delayed start
ofgrowth in intact females was due to inhibition by the ovarian secretion and not
to a lack ofstimulation by the testicular hormones.
Oestradiol dipropionate also considerably increased the latent period of the
grafts and so it waspresum-ably this component ofthe ovarian secretion which was
the inhibiting agent. This effect of oestrogen is conipletely opposite to that
observed by Gardner (1945) with a tumour of similar origin which grew only in
the presence ofoestrogen.
The latent period of 36 days which was observed in ovariectomised females
(Experiment 4), where no oestrogen was present, was extended by 20 days when
the observations were made in the presence of the ovarian secretion of normal
females (Experiment 1). When, by injecting the hormone, the exposure to
oestrogen was made continuous, the latent period (121 days) was 85 days longer. Thus an effective level ofoestrogen could only have been present for a part of the
time in the normal female.
The latent period of the grafts in normal females was not altered by testos-
terone injection (Experiment 5), although vaginal indications of oestrus were
suppressed. This stiggests that in the treated mice the level ofoestrogen secretion
was unaltered, and the castration effects of testosterone were not due to an
inhibition of oestrogen secretion.
Oestradiol dipropionate and stilboestrol were equally effective in prolonging the latent period, whereas tri-phenyl-ethylene and the related compounds tri-
phenyl-chlor-ethylene and aa-(p-hydroxyphenyl-,d-bromo-ethylene) were inactive.
As these fivecompounds all possess the usualproperties associated withoestrogens, their capacity for tumour inhibition in these experiments must be ahighly specific characteristic not implicit in oestrogenic activity.GRAFTED CARCINOMA OF TESTIS 709
It was found (Ellis, 1944) that some human mannnary cancers, particularly
among post-menopausal women, are inhibited or regress with oestrogen therapy.
It may be, therefore, that some incipient mahgnant tumours of the breast are
held in check by oestrogen during ovarian activity, but are able to grow without
restraint when oestrogen secretion ceases at the menopause.
The latent periods of the auto-transplants (Table IV) were not significantly
different from those of the initial grafts and it is interesting to note that a recur-
rence in the operation scaronly arose after a similarlapse oftime. Thus the con-
siderable interval necessary before these grafts began to grow was consequent
on the dislodging of the tumour cells from their established position and not to
the strange environment of a new host.
Transplantation of a tumour, especiaRy autotransplantation, may be regarded
asexperimentalmetastasisandGardner(I945)hasindicatedthepossibleimportance
of hormonal mechanisms in the long delayed recurrences ofprimary tumours and
growth of metastases in human cancer. It is obvious that'if the latent period of
metastasescould be extendedtherapeuticallybeyond the normalIffe-span a virtual
cure would be effected in those cases where the primarygrowth is removed.
SUMMARY.
1. Eight to ten years after the first transplantation the latent period of a
transplanted interstitial cell carcinoma of the testis, induced by triphenyl-ethy-
lene in a Strong A mouse, was found to vary according to the hormonal environ-
ment of the host.
2. The latent period was similar in normal males or castrates ofeither sex, but
was prolonged in normal females.
3. Oestradiol dipropionate and stilboestrol treatment of castrates extended
the latent periodbeyond that observed in normal females, but three other oestro-
gens, tri-phenyl-ethylene, tri-phenyl-chlorethylene and =-(p-hydroxyphenyl)-'8-
bromo-ethylene, had no effect. Testosterone treatment ofnormal females did not
affect the latent period.
4. The tumour transplants became less susceptible to hormonal conditions
during the 2 years ofobservation.
I am indebted to Dr. A. L. Walpole of the Imperial Chemical Industries Ltd.,
Manchester, who supplied the aa.-(p-hydroxy-phenyl)-.6-bromo-ethylene.
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